OSCR

Sigma-1 Expression in Chronic Mouse Models of Temporal Lobe Epilepsy.

Overview

Authors: Victoria Magna Stocker1, Christian Lad1,2, Aleksandr Markov1,2, Heidrun Potschka1, Eva-Lotta von Rüden1
  1. Institute of Pharmacology, Toxicology, and Pharmacy, Ludwig-Maximilians-Universität München (LMU),Königinstr. 16, 80539 Munich, Germany
  2. Graduate School of Systemic Neurosciences, Munich Center for Neurosciences - Brain & Mind (MCN), Ludwig-Maximilians-Universität (LMU) München,Munich, Germany
Journal: Molecular neurobiology, volume 63, issue 1, article 855
Dates: received 18 February 2026; accepted 14 August 2026; published online 25 August 2026; in print 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1007/s12035-026-06155-6 · PMID 42642676 · PMCID PMC13506606 · OpenAlex W7204199648
Open access: hybrid, a free copy (OpenAlex)
Status: data only
Categories: histology / microscopy (modality), mouse (organism), epilepsy (population), cellular / molecular (subfield)
Methods: Statistics, Connectivity
Keywords: Antiseizure medication, Temporal lobe epilepsy, Intrahippocampal kainate model, Amygdala kindling model, Immunohistochemistry, Target validation
MeSH: Epilepsy, Temporal Lobe*, Receptors, sigma*, Amygdala, Animals, Astrocytes, Chronic Disease, Disease Models, Animal, Hippocampus, Kainic Acid, Kindling, Neurologic, Male, Mice, Mice, Inbred C57BL, Neurons, Sigma-1 Receptor (* major topic)
Topic: Pharmacological Receptor Mechanisms and Effects (Molecular Biology, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Funding: Ludwig-Maximilians-Universität München (1024)
Citations: not cited yet (Europe PMC); 101 references in the paper

Abstract

Sigma-1 is an atypical receptor protein that modulates neuronal excitability and cellular stress responses, making it a promising target for therapeutic epilepsy management. However, its expression profile following epileptogenic insults, during epileptogenesis, and following chronic epilepsy manifestation remains unclear. We investigated brain Sigma-1 expression immunohistochemically and via quantitative PCR in two chronic mouse models of temporal lobe epilepsy: the amygdala kindling and intrahippocampal kainate model. Thereby, different disease phases were considered from the early phase following an epileptogenic insult, epileptogenesis, to the chronic epileptic state with recurrent seizures. Sigma-1 expression was largely stable across the examined brain areas. Transient increases in expression intensity were observed 2 days after status epilepticus in the kainate model in the CA3 region of the hippocampus and the entorhinal cortex, whereas no persistent protein-level reductions were detected in the chronic phase. Descriptive coexpression analyses indicated Sigma-1 expression in excitatory and inhibitory neurons, astrocytes, and microglia. These findings indicate that Sigma-1 expression is preserved during epileptogenesis and chronic epilepsy, supporting the continued consideration of Sigma-1 as a potential therapeutic target in epilepsy management. The early alterations observed following an epileptogenic insult further support the rationale for investigating Sigma-1-directed interventions during epileptogenesis, including preventive antiepileptogenic approaches.

Supplementary Information: The online version contains supplementary material available at 10.1007/s12035-026-06155-6.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data Availability

The data are available through Figshare [10.6084/m9.figshare.33287073].

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Publisher: n/a → Springer Science+Business Media

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 5 authors, 6 keywords, 15 MeSH terms, 1 funder, 100 references.

Cite

This paper

Stocker, V. M., Lad, C., Markov, A., Potschka, H., & von Rüden, E.-L. (2026). Sigma-1 Expression in Chronic Mouse Models of Temporal Lobe Epilepsy. Molecular neurobiology, 63(1), 855. https://doi.org/10.1007/s12035-026-06155-6

BibTeX

@article{stocker2026sigma,
author = {Stocker, Victoria Magna and Lad, Christian and Markov, Aleksandr and Potschka, Heidrun and von Rüden, Eva-Lotta},
title = {{Sigma-1 Expression in Chronic Mouse Models of Temporal Lobe Epilepsy}},
journal = {Molecular neurobiology},
year = {2026},
month = aug,
volume = {63},
number = {1},
pages = {855},
publisher = {Springer Science+Business Media},
issn = {0893-7648},
doi = {10.1007/s12035-026-06155-6},
url = {https://doi.org/10.1007/s12035-026-06155-6},
pmid = {42642676},
pmcid = {PMC13506606}
}

RIS

TY - JOUR
AU - Stocker, Victoria Magna
AU - Lad, Christian
AU - Markov, Aleksandr
AU - Potschka, Heidrun
AU - von Rüden, Eva-Lotta
TI - Sigma-1 Expression in Chronic Mouse Models of Temporal Lobe Epilepsy
T2 - Molecular neurobiology
J2 - Mol Neurobiol
PY - 2026
DA - 2026/08/25
VL - 63
IS - 1
SP - 855
SN - 0893-7648
PB - Springer Science+Business Media
DO - 10.1007/s12035-026-06155-6
UR - https://doi.org/10.1007/s12035-026-06155-6
LA - en
ER -

CSL-JSON

{
"id": "10.1007/s12035-026-06155-6",
"type": "article-journal",
"title": "Sigma-1 Expression in Chronic Mouse Models of Temporal Lobe Epilepsy",
"container-title": "Molecular neurobiology",
"author": [
{
"family": "Stocker",
"given": "Victoria Magna"
},
{
"family": "Lad",
"given": "Christian"
},
{
"family": "Markov",
"given": "Aleksandr"
},
{
"family": "Potschka",
"given": "Heidrun"
},
{
"family": "von Rüden",
"given": "Eva-Lotta"
}
],
"container-title-short": "Mol Neurobiol",
"volume": "63",
"issue": "1",
"page": "855",
"DOI": "10.1007/s12035-026-06155-6",
"PMID": "42642676",
"PMCID": "PMC13506606",
"ISSN": "0893-7648",
"publisher": "Springer Science+Business Media",
"URL": "https://doi.org/10.1007/s12035-026-06155-6",
"language": "en",
"issued": {
"date-parts": [
[
2026,
8,
25
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.3389/fphar.2026.1830847 [code]
Sigma-1 and Sigma-2 receptors exhibit divergent genome-wide Co-expression architectures in human brain despite shared subcellular localization.
Journal: Frontiers in pharmacology
In common: cellular / molecular, 5 references
[2] doi:10.3389/fneur.2026.1793970 [code]
The cumulative impact of seizures: the science underlying how seizures beget seizures.
Journal: Frontiers in neurology
In common: epilepsy, 4 references
[3] doi:10.1016/j.isci.2026.116092
Sigma-1 receptor promotes glycolysis in neuronal systems by suppressing GRIM19.
Journal: iScience
In common: mouse, cellular / molecular, 3 references
[4] doi:10.1038/s41598-026-40684-3
Escape behaviors are transiently modulated after acutely induced epileptic seizures in larval zebrafish.
Journal: Scientific reports
In common: epilepsy, 3 references
[5] doi:10.1093/braincomms/fcag323 [code]
Induced epileptic seizures in larval zebrafish reveal a synaptic modulation associated with the post-ictal state.
Journal: Brain communications
In common: epilepsy, histology / microscopy, cellular / molecular, 2 references
[6] doi:10.1002/cns.70979
1 Hz Low-Frequency Repetitive Transcranial Magnetic Stimulation Ameliorates Epilepsy by Suppressing Interferon-γ Signaling-Dependent Microglial Synaptic Phagocytosis in Mice.
Journal: CNS neuroscience & therapeutics
In common: epilepsy, mouse, cellular / molecular, 2 references
[7] doi:10.1016/j.isci.2026.116563
Microglia and its P2RY12 receptors regulate seizure severity.
Journal: iScience
In common: epilepsy, mouse, cellular / molecular, 2 references
[8] doi:10.7554/elife.101859 [code]
On-demand seizures facilitate rapid screening of therapeutics for epilepsy.
Journal: eLife
In common: epilepsy, mouse, 2 references
[9] doi:10.1093/brain/awaf435 [code]
SUR1-TRPM4 is expressed in human epilepsy and promotes neuron hyperactivity and seizures in rodents.
Journal: Brain : a journal of neurology
In common: epilepsy, histology / microscopy, mouse, 1 other category, 1 reference
[10] doi:10.3390/ijms27146326
Increased Cannabinoid Receptor 1-Immunopositive Perisomatic Input of Principal Cells in Human Epileptic Patients in Focal Cortical Dysplasia Type IIB.
Journal: International journal of molecular sciences
In common: epilepsy, histology / microscopy, cellular / molecular, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.